Dec 19, 2022
MEETING BRIEF
AHA 2022
The latest news from AHA 2022, including abstracts, featured articles, and information about the conference.
AHA 2022 eBook
AHA 2022 eBook
A curated ebook of recent studies, findings, and thought leader perspectives from AHA 2022.
Baseline Cholesterol Biomarkers Impact CV Risk in Elderly Patients
Baseline Cholesterol Biomarkers Impact CV Risk in Elderly Patients
Individuals with hypercholesterolemia who had higher levels of campesterol experienced...
Advertisement
PW QUIZ
Advertisement
Returning Secondary Findings Related to Hypercholesterolemia Has Clinical Benefits
Returning Secondary Findings Related to Hypercholesterolemia Has Clinical Benefits
Limited research has been done on outcomes after the return of secondary findings in...
PCSK9 Monoclonal Antibody Provides ‘Significant and Durable’ Decrease in LDL-C
PCSK9 Monoclonal Antibody Provides ‘Significant and Durable’ Decrease in LDL-C
Tafolecimab provided significant, durable decreases in low-density lipoprotein cholesterol...
VICTORION-INCEPTION: Inclisiran Immediately After ACS for Secondary Prevention
VICTORION-INCEPTION: Inclisiran Immediately After ACS for Secondary Prevention
VICTORION-INCEPTION is a phase IIIb, randomized, parallel-group, open-label, multicenter,...
ORION-3: Long-Term Inclisiran Safe & Feasible
ORION-3: Long-Term Inclisiran Safe & Feasible
The principal finding from a 4-year open-label extension study of inclisiran—a small...
Health Informatics Approach to Investigation of FH
Health Informatics Approach to Investigation of FH
West Virginia has widespread cardiovascular disease (CVD), which may be associated with...
Efficacy and Safety of Inclisiran: Pooled Analysis
Efficacy and Safety of Inclisiran: Pooled Analysis
ASCVD is the primary cause of death for women despite having a later onset than it is for men,...
EXPLORE MORE
PCSK9 & LDL-C Reduction in Response to RNAi Therapeutic Inclisiran
The ORION-1 experiment showed that inclisiran, an RNAi treatment that prevents PCSK9 production...
The Genetic Variant P.(Lys3344Glu) in APOB Causes FH
Although there are many genetic polymorphisms in the APOB gene, it is not known whether or not...
Advertisement
Schedule At A Glance
Friday, 11/4 8:00 AM CST - 12:00 PM CST Early Career Programming 12:00 PM CST - 6:00 PM CST...
Conference App
Whether you want to watch the AHA sessions on the go, check out abstracts, or sync your...
Special Lectures
Interested in the special lectures that will happen at AHA this year? Here's a list of what you...
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
